Amanda M. Williams net worth and biography

Amanda Williams Biography and Net Worth

Director of Aclarion

Ms. Williams is currently the Senior Vice President of Clinical and Regulatory at Cordis. She brings 20 years of experience in the medical device space to the Aclarion board. She was the Head of Regulatory with the Image Guided Therapy Devices and Systems divisions of Philips and the Senior Director and Vice President of Clinical and Regulatory with The Spectranetics Corp., (now part of Philips).

From 2003 to 2010 she was Manager, and then Director of Regulatory of AGA Medical Corp (now part of Abbott). Prior to these roles, she worked as a Regulatory Specialist with Vascular Solutions and as a Chemist with GE – Osmonics. She holds a Master’s of Science in Regulatory from Northeastern University and a Bachelor’s of Science in Chemistry from the University of Minnesota.

What is Amanda M. Williams' net worth?: The estimated net worth of Amanda M. Williams is at least $61.28 thousand as of August 17th, 2026. Williams owns 25,857 shares of Aclarion stock worth more than $61,281 as of October 8th. This net worth approximation does not reflect any other assets that Williams may own. Learn More about Amanda M. Williams' net worth.
How do I contact Amanda M. Williams?: The corporate mailing address for Williams and other Aclarion executives is 8181 Arista Place, Ste 100, Broomfield, CO, 80021. Aclarion can also be reached via phone at 833-275-2266. Learn More on Amanda M. Williams' contact information.
Has Amanda M. Williams been buying or selling shares of Aclarion?: Amanda M. Williams has not been actively trading shares of Aclarion during the last quarter. Most recently, on Monday, August 17th, Amanda M. Williams bought 5,857 shares of Aclarion stock. The stock was acquired at an average cost of $2.73 per share, with a total value of $15,989.61. Following the completion of the transaction, the director now directly owns 25,857 shares of the company's stock, valued at $70,589.61. Learn More on Amanda M. Williams' trading history.
Who are Aclarion's active insiders?: Aclarion's insider roster includes Gregory Gould (CFO), Gregory Gould (CFO), David Neal (Director), Brent Ness (CEO), Brent Ness (Chief Executive Officer, President, and Director), and Amanda Williams (Director). Learn More on Aclarion's active insiders.
Are insiders buying or selling shares of Aclarion?: During the last twelve months, Aclarion insiders bought shares 11 times. They purchased a total of 67,888 shares worth more than $176,647.43. The most recent insider tranaction occured on August, 17th when Director Amanda M Williams bought 5,857 shares worth more than $15,989.61. Insiders at Aclarion own 0.0% of the company. Learn More about insider trades at Aclarion.
Information on this page was last updated on 8/17/2026.

Amanda M. Williams Insider Trading History at Aclarion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/17/2026	Buy	5,857	$2.73	$15,989.61	25,857

Amanda M. Williams Buying and Selling Activity at Aclarion

Aclarion Company Overview

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Today's Range

Now: $2.35

$2.32

$2.41

50 Day Range

MA: $2.46

$2.02

$2.94

2 Week Range

Now: $2.35

$1.95

$12.03

Volume

21,449 shs

Average Volume

325,158 shs

Market Capitalization

$6.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2